Search

Search Constraints

You searched for: Author/Creator Federico, Massimo

Search Results

1. Outcome of transformed follicular lymphoma worsens according to the timing of transformation and to the number of previous therapies. A retrospective multicenter study on behalf of Fondazione Italiana Linfomi (FIL). (21st February 2019)

3. A prospective cohort study of patients with peripheral T‐cell lymphoma in the United States. Issue 7 (2nd December 2016)

4. Rituximab with cyclophosphamide, vincristine, non-pegylated liposomal doxorubicin and prednisone as first-line treatment for splenic marginal zone lymphoma: a Fondazione Italiana Linfomi phase II study. Issue 12 (2nd December 2015)

5. Efficacy of bendamustine and rituximab in splenic marginal zone lymphoma: results from the phase II BRISMA/IELSG36 study. (8th November 2018)

6. Positron-emission tomography–based staging reduces the prognostic impact of early disease progression in patients with follicular lymphoma. (February 2020)

8. Survival outcomes of patients with extranodal natural-killer T-cell lymphoma: a prospective cohort study from the international T-cell Project. Issue 4 (April 2020)

9. EHA/ESMO Clinical Practice Guidelines for the Management of Malignant Lymphoma: Recommendations for the Second Phase of the COVID-19 Pandemic. Issue 2 (27th February 2021)

10. Primary refractory follicular lymphoma: a poor outcome entity with high risk of transformation to aggressive B cell lymphoma. (November 2021)